According to the “Health” website, a new study has discovered evidence in mouse and human brain tissues that may explain disparities and the cause of women being diagnosed with Alzheimer’s disease twice as frequently as males.
According to researchers from the University of Kis Western in the American Cleveland, female brains showed a higher expression of a male brain enzyme called the UPEC -11 (USP11) enzyme (USP11), this led to a greater accumulation of a protein called Tau associated with Alzheimer’s disease.
David Kang, a co-author of the study, stated that it “sets a foundation for characterising other characteristics related with chromosomal X, which can give higher ability to infection in women.”
“The fact that USP11 is an enzyme and can typically be blocked by medications is excellent news in terms of the consequences. In order to shield women from the risk of Alzheimer’s disease, we hope to develop a medication that functions in this way “In a news statement, Kang stated.
The fact that women have substantially greater levels of the brain Tau deposits linked to Alzheimer’s disease is one of the possible causes for the rise in Alzheimer’s disease in females.
According to the study, the Tau protein is given a chemical mark called Yobikoyen as the first step in getting rid of the Tao overabundance, but if there is a functional imbalance during this process, the Tau protein may begin to accumulate abnormally.
Alzheimer’s disease affects women more frequently than men due to the X chromosome.
About Author
